Germany
Japan
United Kingdom
China
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
.jpg?d=110x100 "User supplied image")
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR102D11
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR094F2
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR102D11
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
GFAP Capture mouse monoclonal antibody, Luminex validated, clone OTI4D11
| Applications | LMNX |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Matched ELISA Pair | TA700041 |
USD 379.00
In Stock
USD 428.00
In Stock
USD 379.00
In Stock
Rabbit monoclonal anti-ASSY antibody for SISCAPA, clone OTIR3F5
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-SPTB1 antibody for SISCAPA, clone OTIR2D2
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-SODM antibody for SISCAPA, clone OTIR4G8
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-ANK1 antibody for SISCAPA, clone OTIR3A12
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 428.00
In Stock
Rabbit monoclonal anti-ST13 Antibody, clone OTIR191G8
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-POSTN antibody for SISCAPA, clone OTIR1A5
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-TAGL antibody for SISCAPA, clone OTIR1F8
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-COL11 antibody for SISCAPA, clone OTIR1C9
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-SPTN2 antibody for SISCAPA, clone OTIR4E9
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-RFA2 antibody for SISCAPA, clone OTIR2G2
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-HSBP1 antibody for SISCAPA, clone OTIR5C4
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 428.00
In Stock
Rabbit monoclonal anti-EBP2 antibody for SISCAPA, clone OTIR3D2
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-TKT antibody for SISCAPA, clone OTIR4F5
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-RMD3 antibody for SISCAPA, clone OTIR1A2
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-IASPP antibody for SISCAPA, clone OTIR1G11
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-MIME antibody for SISCAPA, clone OTIR4H1
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-PARK7 antibody for SISCAPA, clone OTIR4F10
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-FABP4 antibody for SISCAPA, clone OTIR5E9
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-TXND5 antibody for SISCAPA, clone OTIR4D8
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-NNMT antibody for SISCAPA, clone OTIR1F6
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-PDIA3 antibody for SISCAPA, clone OTIR5G4
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-P5CR1 antibody for SISCAPA, clone OTIR1E8
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-CADH6 antibody for SISCAPA, clone OTIR5A6
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-CHK1 antibody for SISCAPA, clone OTIR3G7
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Mouse
Clonalities
- Monoclonal
Conjugates
- Unconjugated
Filter by
Target Symbol
- VSNL1 (165)
- ALK (162)
- MAP2K1 (131)
- ERBB2 (117)
- NME1 (104)
- ABCB1 (96)
- JUN (95)
- ERCC1 (93)
- GLI1 (90)
- MAP2K3 (90)
- CTNNB1 (79)
- GADD45G (78)
- OTC (75)
- VIM (73)
- EGFR (71)
- PCNA (66)
- PIK3C2A (66)
- LGALS3 (64)
- NUMB (64)
- TOP2A (60)
- L1CAM (57)
- MAPK13 (57)
- UBE2E3 (57)
- PDCD1 (54)
- SENP2 (54)
- F13A1 (53)
- APP (52)
- NKX2-1 (52)
- PNMT (51)
- TYMS (51)
- MLH1 (49)
- ALDH1L1 (48)
- MIEN1 (48)
- BRAF (47)
- AKT1 (46)
- LGR5 (46)
- SYP (45)
- BCL2 (44)
- PARVA (44)
- NCAM1 (42)
- SPG7 (42)
- UBA52 (42)
- GFAP (41)
- ABAT (40)
- SQSTM1 (40)
- AFAP1 (39)
- BCL10 (39)
- CNOT4 (39)
- PIK3AP1 (39)
- PTPRE (39)
- SNAI2 (39)
- STAT5A (39)
- LOX (38)
- CBX8 (37)
- LTA4H (37)
- BBOX1 (36)
- ERG (36)
- FSHB (36)
- LPL (36)
- MAPK1 (36)
- MEF2C (36)
- MIOX (36)
- MMP13 (36)
- PIK3CG (36)
- PSMC3 (36)
- RNF144B (36)
- ZFP36 (36)
- BTK (35)
- MTOR (35)
- TLE1 (35)
- EFNA2 (34)
- FGFR2 (34)
- KCNAB1 (34)
- LDLRAP1 (34)
- MSI1 (34)
- PRKCE (34)
- SMS (34)
- STAT4 (34)
- VBP1 (34)
- ACAT2 (33)
- ARHGAP25 (33)
- CCM2 (33)
- CDK2 (33)
- CRYAB (33)
- DPP9 (33)
- ERCC4 (33)
- KRAS (33)
- MAPK7 (33)
- MCM2 (33)
- MOB3B (33)
- NAB1 (33)
- NPR3 (33)
- NRBF2 (33)
- PCDH7 (33)
- PSMD2 (33)
- RRM1 (33)
- SOCS3 (33)
- TNNT2 (33)
- TTLL12 (33)
- UPRT (33)
Applications
Antibody Hosts
Isotypes
Carrier-free
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (34)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- Phospho-specific (10)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- Modification (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric hamster (Armenian) antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (2)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (2)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
- This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (14026)
- Transcription Factors (4475)
- Transmembrane (2721)
- Protein Kinase (2153)
- ES Cell Differentiation/IPS (1755)
- Stem cell - Pluripotency (1051)
- Protease (1024)
- Secreted Protein (1006)
- Adult stem cells (444)
- Nuclear Hormone Receptor (403)
- Phosphatase (315)
- Embryonic stem cells (298)
- Cancer stem cells (275)
- Stem cell relevant signaling - DSL/Notch pathway (198)
- Stem cell relevant signaling - JAK/STAT signaling pathway (195)
- Ion Channels: Other (126)
- Induced pluripotent stem cells (123)
- GPCR (109)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (92)
- P450 (52)
- Stem cell relevant signaling - Wnt Signaling pathway (36)
- Ion Channels: Potassium (34)
- Ion Channels: Cys-loop Receptors (18)
- Ion Channels: Transient receptor potential (8)
- Ion Channels: Calcium (3)
- Ion Channels: Glutamate Receptors (2)
- Ion Channels: Sodium (2)
- Ion Channels: Cyclic nucleotide gated (1)
Pathways
- Metabolic pathways (2545)
- Pathways in cancer (2067)
- MAPK signaling pathway (1545)
- Focal adhesion (1284)
- Prostate cancer (1106)
- Colorectal cancer (1046)
- ErbB signaling pathway (1005)
- Neurotrophin signaling pathway (980)
- Endometrial cancer (846)
- Regulation of actin cytoskeleton (824)
- Insulin signaling pathway (823)
- Pancreatic cancer (816)
- T cell receptor signaling pathway (814)
- Progesterone-mediated oocyte maturation (781)
- B cell receptor signaling pathway (776)
- Toll-like receptor signaling pathway (773)
- Non-small cell lung cancer (770)
- GnRH signaling pathway (742)
- Melanoma (731)
- Renal cell carcinoma (719)
- Glioma (717)
- Fc epsilon RI signaling pathway (709)
- Chronic myeloid leukemia (678)
- Acute myeloid leukemia (670)
- Bladder cancer (629)
- Chemokine signaling pathway (595)
- VEGF signaling pathway (578)
- Cell cycle (571)
- Purine metabolism (549)
- Endocytosis (545)
- Gap junction (545)
- Wnt signaling pathway (539)
- Adherens junction (501)
- Fc gamma R-mediated phagocytosis (482)
- Natural killer cell mediated cytotoxicity (475)
- Leukocyte transendothelial migration (473)
- Small cell lung cancer (457)
- Epithelial cell signaling in Helicobacter pylori infection (435)
- Oocyte meiosis (434)
- Thyroid cancer (421)
- Alzheimer's disease (418)
- Pyrimidine metabolism (418)
- Melanogenesis (404)
- mTOR signaling pathway (403)
- Calcium signaling pathway (393)
- Ubiquitin mediated proteolysis (392)
- Long-term potentiation (387)
- Apoptosis (383)
- Axon guidance (380)
- Tight junction (371)
- Jak-STAT signaling pathway (369)
- Long-term depression (357)
- Type II diabetes mellitus (350)
- Amyotrophic lateral sclerosis (ALS) (348)
- Vascular smooth muscle contraction (322)
- Nucleotide excision repair (317)
- Glycolysis / Gluconeogenesis (313)
- Adipocytokine signaling pathway (299)
- Arginine and proline metabolism (295)
- Basal cell carcinoma (295)
- Dorso-ventral axis formation (295)
- Huntington's disease (291)
- Pathogenic Escherichia coli infection (286)
- Hedgehog signaling pathway (281)
- p53 signaling pathway (281)
- Cytokine-cytokine receptor interaction (275)
- Cell adhesion molecules (CAMs) (274)
- Prion diseases (269)
- Parkinson's disease (247)
- TGF-beta signaling pathway (247)
- Proteasome (240)
- RNA degradation (221)
- NOD-like receptor signaling pathway (219)
- Valine (215)
- Phosphatidylinositol signaling system (208)
- leucine and isoleucine degradation (208)
- Inositol phosphate metabolism (203)
- Spliceosome (201)
- Mismatch repair (193)
- Hypertrophic cardiomyopathy (HCM) (188)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (187)
- Alanine (182)
- aspartate and glutamate metabolism (182)
- DNA replication (181)
- Oxidative phosphorylation (179)
- Notch signaling pathway (173)
- Dilated cardiomyopathy (172)
- Pyruvate metabolism (166)
- Tyrosine metabolism (163)
- Base excision repair (162)
- One carbon pool by folate (162)
- RIG-I-like receptor signaling pathway (153)
- Butanoate metabolism (152)
- Fatty acid metabolism (152)
- Lysine degradation (151)
- Propanoate metabolism (144)
- ABC transporters (141)
- Antigen processing and presentation (132)
- Neuroactive ligand-receptor interaction (130)
- Glutathione metabolism (128)
- Glycine (128)
- serine and threonine metabolism (128)
- Maturity onset diabetes of the young (120)
- Primary immunodeficiency (117)
- PPAR signaling pathway (114)
- Vibrio cholerae infection (112)
- Arachidonic acid metabolism (109)
- Cardiac muscle contraction (106)
- Histidine metabolism (105)
- Tryptophan metabolism (104)
- beta-Alanine metabolism (104)
- Citrate cycle (TCA cycle) (97)
- SNARE interactions in vesicular transport (94)
- Cysteine and methionine metabolism (87)
- Amino sugar and nucleotide sugar metabolism (85)
- Circadian rhythm - mammal (83)
- Pentose phosphate pathway (83)
- Porphyrin and chlorophyll metabolism (83)
- Glycerolipid metabolism (81)
- Starch and sucrose metabolism (81)
- Viral myocarditis (80)
- Complement and coagulation cascades (78)
- Drug metabolism - other enzymes (78)
- Drug metabolism - cytochrome P450 (75)
- Terpenoid backbone biosynthesis (75)
- Ribosome (73)
- Fructose and mannose metabolism (70)
- Lysosome (69)
- Methane metabolism (67)
- RNA polymerase (67)
- Fatty acid elongation in mitochondria (66)
- Retinol metabolism (62)
- Regulation of autophagy (59)
- Metabolism of xenobiotics by cytochrome P450 (58)
- Hematopoietic cell lineage (57)
- Cytosolic DNA-sensing pathway (56)
- Glyoxylate and dicarboxylate metabolism (54)
- Renin-angiotensin system (53)
- ECM-receptor interaction (52)
- Selenoamino acid metabolism (50)
- Ascorbate and aldarate metabolism (49)
- Nicotinate and nicotinamide metabolism (49)
- Systemic lupus erythematosus (49)
- Galactose metabolism (48)
- N-Glycan biosynthesis (48)
- Nitrogen metabolism (46)
- Type I diabetes mellitus (43)
- Synthesis and degradation of ketone bodies (42)
- Basal transcription factors (41)
- Folate biosynthesis (37)
- Olfactory transduction (37)
- Phenylalanine metabolism (36)
- Glycerophospholipid metabolism (34)
- Androgen and estrogen metabolism (32)
- Homologous recombination (31)
- Sulfur metabolism (30)
- Ether lipid metabolism (27)
- Primary bile acid biosynthesis (27)
- Other glycan degradation (24)
- Pantothenate and CoA biosynthesis (24)
- Sphingolipid metabolism (24)
- Caffeine metabolism (22)
- Aminoacyl-tRNA biosynthesis (21)
- Riboflavin metabolism (19)
- Cyanoamino acid metabolism (18)
- Thiamine metabolism (18)
- Vitamin B6 metabolism (18)
- Keratan sulfate biosynthesis (15)
- Fatty acid biosynthesis (14)
- Non-homologous end-joining (14)
- Glycosphingolipid biosynthesis - lacto and neolacto series (13)
- Limonene and pinene degradation (13)
- Glycosaminoglycan degradation (12)
- Taste transduction (12)
- Autoimmune thyroid disease (11)
- Allograft rejection (10)
- Graft-versus-host disease (10)
- leucine and isoleucine biosynthesis (10)
- D-Glutamine and D-glutamate metabolism (9)
- Phenylalanine (9)
- Taurine and hypotaurine metabolism (9)
- tyrosine and tryptophan biosynthesis (9)
- Biosynthesis of unsaturated fatty acids (7)
- Linoleic acid metabolism (7)
- O-Glycan biosynthesis (6)
- Protein export (6)
- Steroid biosynthesis (6)
- alpha-Linolenic acid metabolism (6)
- Pentose and glucuronate interconversions (5)
- Glycosphingolipid biosynthesis - ganglio series (3)
- Ubiquinone and other terpenoid-quinone biosynthesis (3)